StonvexLoading…
StonvexStonvexStonvexCore line items from AVBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $145.75M | $142.44M |
Operating Income | $-26.97M | $29.80M |
Net Income | $-19.55M | $21.02M |
EPS (Diluted) | $-2.25 | $2.76 |
Total Assets | $2.57B | $2.30B |
Total Liabilities | $2.29B | $2.12B |
Cash & Equivalents | $154.57M | $82.70M |
Free Cash Flow OCF − CapEx | $38.94M | $22.64M |
Shares Outstanding | 10.95M | 7.91M |